astria therapeutics glp-1 receptor agonist weight management diabetes treatments Randomised trial comparing loss through lifestyle and therapy in people with MASLD Mapping the effectiveness and risks

Association between bariatric surgery and macrovascular disease outcomes in patients with type 2 diabetes and severe obesity

A study in the Journal of the American Medical Association supported that view, along with one in the journal Diabetes, Obesity and Metabolism that found that after stopping semaglutide for one year, people had regained two-thirds of the weight they had lost

Niazi says GLP-1 therapy is most effective when people also receive support for nutrition, exercise, and sleep

The researchers discovered that an area in the brain, called the median preoptic nucleus, is likely mediates GLP-1 drugs effects on thirst

In humans it is synthesised by the gene GLP1R , which is present on chromosome 6